Immune mechanisms have been suggested to play a role in the natural disease course of RCC. The objective of this study was to examine factors that may be involved in the signifi cant survival benefi t of immunotherapy for RCC patients. A low frequency of total or HLA haplotype loss was found and, in parallel, the tumour tissue expressed more HLA classI/ B2m mRNA. These data signifi cantly differ from those reported in other epithelial tumours. Furthermore, chemokines and their receptors play key roles in leukocyte traffi cking and are also implicated in cancer metastasis. We identifi ed a number of chemokines that were highly expressed in RCC versus normal tissue. RT-PCR analysis showed expression of antiangiogenic agents I-TAC and IP-10, and proinfl ammatory chemokines MIP-1a and RANTES in RCC tissues and very weak or undetectable expression in most of the normal kidney tissues. In contrast, the angiogenic SDF-1 was more strongly detected in the normal tissue. This chemokine production pattern was correlated with a preferential recruitment of CD4+ Th1-polarized effector memory cells that express CXCR3/CCR5, monocytes and NK cells. The composition of the tumour infi ltrate was different in more advanced tumours. In conclusion, upregulation of HLA class I gene expression in addition to chemokine expression in the tumour environment may contribute to the successful response of RCC to immunotherapy.
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HLA ASSOCIATIONS WITH HIV-1 INFECTION IN BULGARIAN PATIENTS
Fani Martinova, Roumiana Markova, Ivailo Elenkov, Vera Popova, Velislava Terzieva, Maria Yankova Hospital "Pirogov", NCIPD, Infect. Dis. Hospital, Sofi a, Bulgaria Due to the major role of the HLA locus in controlling the immune response, associations between HLA genes and progression to AIDS have been extensively studied. The aim of the our study was to determine which HLA alleles from class I (HLA-A, -B) and class II (HLA-DRB1) were presented in HIV-1 infected patients.
HLA-A, B and DRB1 alleles were tested in 17 patients with chronic HIV-1 infection. 200 control healthy individual were tested too. Fifteen of the patients were under highly active antiretroviral therapy (HAART) (2NRTIs and 1PI).
The HLA alleles were identifi ed using polymerase chain reaction (PCR)-amplifi ed DNA hybridized with sequence-specifi c probe (SSP).
The frequencies of HLA class I antigens B*47 (p=0.0258, OR=13.665), B*58 (p=0.0258, OR=13.665) and B*65 (p=0.0003) were increased in all HIV-1 positive patients in comparison with the controls. The frequency of the antigen B*35 was weakly and non-signifi cantly increased. HLA-B*7 and B*57 alleles were missing in all patients.
The frequencies of HLA class II antigens DRB1*01 and DRB1*13(*06) have been found increased in patients. The frequency of DRB1*11(*05) has been established decreased in all patients in comparison with controls.
Our fi ndings, although preliminary, suggest that HLA alleles infl uence resistance or susceptibility in a small cohort of HIV-1 infected Bulgarians, investigated up to now. Further studies are in progress to evaluate the correlation between host genetic profi les, progression to AIDS and the clinical outcome of the disease.
36
DISTRIBUTION OF HPA-GENES AND GENOTYPES IN THE POPULATION OF RUSSIAN UNRELATED DONORS
Distribution patterns of HLA haplotypes are important in anthropological, organ transplantation and disease association studies. In the present study we investigated HLA A-B, A-B-DR and DR-DQ haplotype similarities and diversities among UAE nationals, other arabs from neighbouring countries, Indians and Pakistanis,all living in UAE. A total of 145 families: 76 from UAE, 17 from the Arabian gulf peninsula (AGP), 17 from the south Mediterranean region (SMR), 17 from the north of Africa (NA), and 18 from India and Pakistan (ASIANS) were typed by serological methods and /or Low resolution PCR-SSP techniques. Only HLA haplotypes confi rmed by pedigree analysis from family studies have been included. Haplotype frequency is expressed as the % of the population possessing the specifi c HLA A-B, A-B-DR or DR-DQ haplotype. The results of the study suggest that A 26(10)-B8-DR17(3) is the most frequent haplotype in UAE nationals. Haplotypes A2-B50(21), A2-B35-DR16(2), A11-B40-DR16(2), A2-B50(21)-DR7, DR16(2)-DR51-DQ5(1), DR17(3)-DR52-DQ2 are commonly seen in both UAE and AGP groups. The predominant class II HLA haplotype in SMR group, DR11(5)-DR52-DQ3 was not frequent in both UAE and AGP groups. The DR-DQ haplotype in NA group reveals a different split of DR2, DR 15(2)-DR51-DQ1 as compared to the DR16(2)-DR51-DQ1 seen in the UAE and AGP arab groups. Haplotype A2-B51(5) seen in the asian population is also common in UAE nationals. This study identifi es and compares some of the most common HLA A-B, A-B-DR and DR-DQ specifi c haplotypes seen in the south Mediterranean, Gulf regions, north of Africa, India and Pakistan .It also highlights the similarities in class I and II haplotypes between UAE and AGP arab groups.
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INFLUENCE OF HLA-DRB1 IN CLINICAL COURSE AND DISEASE SEVERITY IN PORTUGUESE MS PATIENTS
Ana M. Silva2, Clara Pereira1, Andreia Bettencourt1, Cláudia Carvalho1,3, Sara Casimiro1, Zulmira Quintas3, Paulo P.Costa3, Luís Monteiro2, Berta M. Silva1,3 1Immunogenetic Laboratory-ICBAS/University of Porto. 2 Neurology Service-HGSA. 3 INSA-Dr.Ricardo Jorge-Porto. Portugal.
The association between susceptibility to multiple sclerosis (MS) and the class II MHC allele HLA-DRB1*15 is well established although a possible relationship between this allele and the clinical course in MS is less clear and controversial.
Our goal is to investigate the impact of HLA-DRB1*15 on clinical forms and severity in Portuguese MS patients.
We studied 195 unrelated patients with clinically defi nitive MS attending the neurological clinics of HGSA: 151 relapsing-remitting MS (RRMS) and 44 secondary progressive MS (SPMS), and 210 healthy controls from the North of Portugal. To evaluate disease severity 82 patients, with disease duration of at least 10 years, were divided in 3 groups: 38 patients were considered to have Benign MS, 30 Non-Benign MS and 14 Aggressive MS. HLA-DR antigens were typed using sequence specifi c primers (PCR-SSP).
As expected, DR15 allele frequency was elevated in patients (p=0.040) but didn't show any difference when we considered RRMS and SPMS patients. In DR15 negative patients, DR3 was positively associated with susceptibility to MS (p=0.032) . Regarding the severity of the disease the frequency of DR15 was signifi cantly higher in patients with benign course (p=0.004).
The association with DR15, primarily observed in patients with benign course, suggests that this allele may constitute a genetic factor of benignity for the course of the disease. Additionally, in our population, HLA-DR3 may be a general susceptibility allele in DR15 negative MS patients.
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CYTOKINE GENE POLYMORPHISM IN A PORTUGUESE CAUCASOID POPULATION
Sandra Balseiro*1,2, Paulo Santos1, Ana Sofi a Gonçalves*1,2, Ramon Salvado3, Fernando Regateiro1 (1) Histocompatibility Center, Coimbra-Portugal; (2) Fac Science and Technology Univ. Coimbra; (3) Coimbra Hospital Center.
In this study, 174 healthy Portuguese Caucasians individuals were genotyped by PCR-SSP for IL-1 , IL-1 , IL-2, IL-4, IL-6, IL-10, IL-12, IFN-, TGF-, TNF-, IL-1R, IL-1RA and IL-4RA using the 13th IHW tray kit (U. Heidelberg). Allelic and genotype frequencies were determined and compared with Italian, English, German and African-American populations.
Although most of cytokine genes were in Hardy-Weinberg equilibrium, there are some exceptions: IL-12 (p<0,05), TGF-(codon 25) (p<0,01), TNF-(p<0,01) and IL-4 (-1098) (p<0,01). The pro-infl ammatory cytokines (IL-12 and TNF-) showed a prevalence of the low producer genotypes. The anti-infl ammatory cytokine (IL-4) and the Th3 cytokine (TGF-) showed a prevalence of the high producer genotypes. We found signifi cant differences between Portuguese and other populations. The Italian population is the population with more similarity (59%) with our population and the African-American population is the population with less similarity (11%). The English and the German populations showed an equivalent similarity (40% and 38%) with the Portuguese population.
Natural selection may be the cause of some cytokines analysed were in disequilibrium in this population, once that there are different genotype patterns for anti and pro-infl ammatory cytokines associated with different rate of production. Cytokine genotyping seems to be an excellent method to study genetic distances between distinguished populations.
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HLA CLASS II PROFILE IN PATIENTS WITH LEPTOSPIROSIS: A PRELIMINARY REPORT
Raquel N. Fialho1, Maria José Peixoto1, Bruno F. Bettencourt1, Ana Rita Couto1, Francisco Garrett1, Margarida R. Santos1, Isa Dutra1, João P. Pinheiro1, Jácome Bruges Armas1 1Serviço Especializado de Epidemiologia e Biologia Molecular, Hospital de Santo Espírito de Angra do Heroísmo (HSEAH) BACKGROUND: Leptospirosis represents an important threat to public health in the Azores islands, especially Terceira and S. Miguel. The fi rst cases were diagnosed in 1986, and the mortality rate is 5-fold the observed in Portugal mainland. To date, there is only one report of association between HLA Class II and Leptospirosis.
METHODS: HLA Class II alleles typing (DR, DQB) was performed on DNA extracted from peripheral blood cells of 51 patients with serological confi rmation and 129 healthy unrelated control individuals by PCR-SSP and PCR-SSO. Allelic and haplotype frequencies were estimated using Arlequin V2.000, and comparisons were performed using Chi-square and Fisher's exact test.
RESULTS: Eighty-eight percent (45) of patients had direct contact with animals, and only 6% (3) were women. Twenty percent of cases (10) involved multiple serogroups. Main serogroups were Icterohaemorrhagiae (47.1% of the cases) and Ballum (37.3%). Allelic HLA frequencies between controls and the Leptospirosis cohort were not statistically different. Haplotype DRB1*04-DQB1*05 was found in 11.8% of the Leptospirosis cohort (p=0.055). DRB1*04 was identifi ed as crucial to the marginal difference between DRB1*04-DQB1*05 frequencies in both cohorts (Woolf's formula).
CONCLUSIONS: 1) No association was established between HLA class II genes and susceptibility to Leptospirosis. 2) Previously reported association between allele DQB1*06 and increased risk of Leptospirosis was not confi rmed.
3) The size of this cohort should be increased in order to enhance the power of the study.
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OCCURRENCE RATES OF CLASS I AND II HLA ALLELES IN PATIENTS SUFFERING FROM LUNG CANCER
Mehmet Merala, Ibrahim Pirimb, Hasan Kaynara, Metin Akguna, Hasan Doganb, Nilnur Egercib, Umran Yildirimc Atatürk University, School of Medicine, aChest Disease, bMedical Biology and Genetic and cPathology Departments, Erzurum, Turkey A relation between HLA antigens and autoimmune disease has long been reported. In other studies, investigators have reported association between various HLA antigens and certain cancers. For example, there have been reports of an association between HLA antigens and lung cancer. 45 patients with lung cancer were studied to compare the incidence of class I and II HLA alleles with a control group of 49 who were healthy donor of kidney and bone marrow in order clearly to identify susceptible and protective HLA alleles in lung cancer. The diagnosis of lung cancer was confi rmed histopathologically. Thirty eight patients had nonsmall cell lung cancer and 7 patients had small cell lung cancer. The patients and the healthy controls were typed for HLA class I and II alleles. HLA DNA typing was performed by PCR/SSP method. The frequencies of HLA-B60, HLA-DR11, HLA-DR14 and HLA-DQ6 were higher in the lung cancer patients than in the control group. However, HLA-A2 frequency was markedly higher in the controls as compared with the patients. The study results suggest that genetic factors infl uence the susceptibility to lung cancer. Analysis of HLA may be important for investigating not only the etiology, but also the therapy and prognosis.
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STUDY OFDQB1* GENE IN ALZHEIMER Y OTHER NEUROLOGICAL DISEASES IN CASTILLA Y LEON (SPAIN)
Victoriano J. Leon, Jesus Cacho1, Silvia Gamazo1, Bernardino Fernandez Calvo1. Serv. Bioquimica.1 Unidad de Demencias, Secc. Neurologia. Hospital Universitario de Salamanca (Spain) Introduction: Epidemiological studies have correlated HLA class II alleles with susceptibility or resistance to certain immune-mediated diseases. In some cases the presence of a particular HLA allele appears to modulate the immune response to certain exo antigens and protects the host from illness, whereas in other cases the host may mount an immune response against self-antigens.
In the present study, we examined the possible association of DQB1* polymorphism with AD and other neurological diseases OND in Castilla y Leon (Spain) population.
Material and Methods: We took samples of whole blood, 50-200mcl, from 64 patients of Alzheimer Disease (AD), 79 of other neurological disease (OND) and 126 control subjects. Blood spots on 3MM fi lter paper were dried and stored at room temperature. DNA was extracted with DNA Direct II kit (Dynal), obtaining 1-4mcg of DNA. Classic SSP DQ "Low resolution" kit of Dynal was employed in this study. We have modifi ed the amount of DNA per tube to 2-4 ng and the concentration of the Taq Polymerase to 0,1 U/tube. The conditions of the PCR had been: 1) 94ºC, 2 min., 1 cycle. 2) 94ºC 10 sec., 65ºC 60 sec. 10 cycles. 3) 94ºC 10 sec., 61ºC 50 sec., 72ºC 30 sec. 30 cycles. 4) 72ºC 3 min.
Results: The allelic distribution in our study are for HLA DQB1*02, *03, *04, *05,and *06 in control group (n=126) , 29, 7; 27, 3; 1, 5; 19, 4; 21, 8. in AD group (n=64)34, 3; 24, 2; 0, 7; 20, 3; 20, 6. and OND (n=158) 26, 6; 32, 3; 0, 6; 18, 3; 20, 7 . The Chi-square test show differences P< 0.001 inter patients groups (AD ,OND and control group). Graves' disease is an autoimmune disease and it is known that is more frequently in some HLA groups. In the literature, it is reported that the frequency of HLA-B*08 and HLA-DRB1*03 in white population with Graves' disease are higher than in Asian population. In one study in Turkey, it was reported that HLA-DR3 and DR 4, HLA-B8 and HLA-B49 were more frequently in patients with Graves' disease. The aim of the present study was to investigate whether any relationship between HLA antigens and Graves'disease.
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GRAVES' DISEASE AND HUMAN LEUKOCYTE ANTIGENS
Therefore, seventy-six Turkish patients with Graves'disease and 133 control subjects were studied. The frequency of HLA-B* 27, DRB*03, B*18 and B*08 alleles in patient group were found higher than control group respectively.
The frequency of HLA-DRB1*04, B*40 and B*21 in patients with Graves' were observed less than control subjects. These fi ndings were different from the other studies in our country because of heterogenecity of Graves' disease, ethnical differences and study techniques.
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MICA MICROSATELLITE POLYMORPHISM AND ASTHMA IN THE CROATIAN CHILDREN POPULATION
Vesna Balog, Zorana Grubic, Katarina Stingl, Renata Zunec, Irena Ivkovic-Jurekovic, Jasna Cepin-Bogovic, Vesna Brkljacic-Kerhin Tissue Typing Centre, University Hospital Zagreb, Croatia So far, there hasn' t been a study, which would investigate the possibility of an association of the fi ve known alleles of the MICA polymorphism with asthma in the Croatian population. Since atopic asthma is still intriguing, regarding its asociation with HLA region, we undertook this study to dissect possible relation. We have studied the MICA polymorphism in 122 children with asthma and 187 unrelated healthy controls. Patients were divided into 2 groups according to differential phenotypic expression of symptoms: group A-asthma only (53 patients) and group B-asthma with rhinitis (69 patiens). Forty three patients had low total IgE level (<400 kU/L), 39 patients had high total IgE (400 -1000 kU/L) and 40 patients had very high total IgE (>1000 kU/L). All patients were Dermatophagoides pteronyssinus (Dp) sensitive; 49 were Ambrosia elatior (Ae) and/or Dactylus glomerata (Dg) sensitive in adition. The MICA polymorphism was determined by PCR and electrophoresis on 6% polycrylamide gel in an automated sequencer (ALFexpress). Alleles were designated using the AlleleLocator program. Using appropriate statistical tests (Fisher exact test and Chi square), no signifi cant association was found between any MICA allele and childhood asthma in our population. The distribution of MICA alleles demonstrated no statistically signifi cant difference either when comparing group A and group B or when the patients were divided according to the total serum IgE or according to the sensitivity to Dp, Ae and Dg. Up to now our results indicate that MICA polymorphism does not play any role in developing asthma in the Croatian children population.
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TNFA PROMOTER POLYMORPHISMS IN PORTUGUESE MULTIPLE SCLEROSIS PATIENTS
Clara Pereira1, Ana M Silva2, Cláudia Carvalho3, Andreia Bettencourt1, Sara Casimiro1, Zulmira Quintas3, Paulo M Costa3, Luís Monteiro2, Berta M Silva1,2. 1Immunogenetics Laboratory-ICBAS/University of Porto; 2Neurology Service -HGSA; 3INSA-Dr. Ricardo Jorge -Porto.
Tumor Necrosis Factor (TNF) is a powerful pro-infl ammatory cytokine with an important role in the modulation of immune functions that has been shown to mediate the autoimmune reactivity against central nervous system (CNS) components. Several reports have suggested the involvement of TNF polymorphisms in multiple sclerosis (MS), a demyelinating CNS disorder primarily associated to HLA-DRB1*15. The aim of this study was to investigate if two single nucleotide polymorphisms (SNPs) in the TNFA gene promoter (-308G>A and -238G>A) could be associated to MS in a group of Portuguese patients.
One-hundred and ninety-fi ve patients with a defi nite diagnose of MS and 210 ethnically matched controls were enrolled. TNFA SNPs genotyping was assessed by melting curve analysis with fl uoroscein-labelled hybridization probes after PCR amplifi cation. HLA typing was performed by PCR-SSP.
The -238A allele frequency was lower in the MS patients in relation to controls (p=0.03, OR=0.433). This result could be suggestive of a general protective role of this allele for MS Portuguese patients. Nonetheless, we have also found an overrepresentation of the -308GG genotype among the HLA-DR*15 positive patients versus DRB1*15 negatives (p=0.001), and confi rmed the presence of LD between the -308G and DRB1*15 alleles in the MS population, but not in the controls. These results support that an extended haplotype including HLA-DRB1*15 and -308G confers susceptibility to MS and suggest that the association of MS with TNF alleles could be secondary to the HLA association.
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DR/DQ ANTIGENS IN PAPILLARY THYROID TUMORS
Teresa Porto1, Ibraim Coelho2, Clara Pereira3, Andreia Bettencourt3, Cláudia Carvalho3, Berta Martins3, Valeriano Leite2,4. 1Imunohemotherapy Service, 2Endocrinology Service, and 4Molecular Pathobiology Research Centre -IPO-FG; 3Immunogenetics Laboratory -ICBAS -University of Porto HLA antigens are well recognised factors that infl uence the development of tumoral pathology. Association of certain HLA alleles with papillary thyroid carcinomas (PTC) have been proposed although this has not been fi rmly established. This work was undertaken to investigate the association of HLA Class II alleles with PTC.
One hundred and eighty one patients with PTC from the centre of Portugal and 315 ethnically matched controls were typed for polymorphic HLA-DR and HLA-DQ antigens. Lymphocyte isolation was performed using immunomagnetic particles coupled to monoclonal antibodies specifi c either for T or B lymphocytes. HLA typing was performed by a microlymphocytotoxicity assay, using monoclonal trays.
PTC patients showed a signifi cantly increased frequency of HLA-DQ4 (p=0.0005, pc=0.0032, OR=4.06, 95%CI=1.82-9.05) and pc=0.186, OR=2.75, ) compared with controls.
Linkage disequilibrium (LD) for these two alleles was tested and confi rmed in the control population (D=0.0130, p=9.7e-57) but not in PTC patients (D=0.038, p=n.s.), suggesting that only one of these alleles is associated with PTC susceptibility.
This data, performed in the largest series of patients with papillary thyroid carcinoma reported to date, combined with previous results reported by Bayram et al. (2004) Psoriasis (PS) is a complex infl ammatory disease associated with an overexpression of pro-infl ammatory cytokines like TNF-a in the involved skin and relative underexpression of Th2 type cytokines. The -308G>A and -238G>A single nucleotide polymorphisms (SNPs) on the TNFA gene promoter have been reported to be involved in the genetic control of TNF-a production. The present study investigates the association of these two SNPs with psoriasis and HLA-Cw*0602 allele in Portuguese patients. HLA-Class I alleles typing was performed in a group of 50 PS patients and 222 ethnically matched healthy individuals by PCR-SSP. TNFA SNPs alleles were determined by melting curve analysis of PCR products with fl uorescein-labelled hybridization probes for the same subjects.
The frequency of the Cw*0602 allele was highly increased in overall PS patients (p=0.004, OR=2.84). There were no statistically signifi cant differences in -238 and -308 TNFA allele's frequencies distribution in PS and controls. However, the -238A rare allele was overrepresented within the PS Cw*0602 positive patients (26.1% vs. 3.7% in the Cw*0602 negatives, p=0.039), even though there were no differences in the -238A allele frequency in Cw*0602 positive versus negative controls. We have further shown that the co-existence of both Cw*0602 and -238A alleles confer higher risk for PS (OR=3.76, p=0.036) than the presence of Cw*0602 alone.
Whether A highly relevant feature of MHC antigens is their co-dominant expression.Since both alleles contribute to phenotype equally, it is reported to be important to investigate the genotypes in disease association studies rather than alleles on their own. MHC is inherited en bloc as a haplotype with the exception of rare recombinational events. Recombination occurs at 1-3% frequency mostly at the HLA-A or HLA-DP ends.Our study involves families including the patients (n=1035) and recipients (n=5485) (mother,father, children) who applied to our lab between 2000-2004. In the study group, HLA-A,-B typings were performed by microlymphocytotoxicity method (Biotest) and HLA-DR typing was performed by PCR-SSP method. Recombination was demonstrated in 12 (0,01%) of the families and those were typed for HLA-A,-B-DR by PCR-SSP for confi rmation (Table1). The haplotypes of the parents in families in which recombination was demonstrated was completely different from each other. Although recombination is a process that occurs spontaneously, increased crossing over frequency in ALL patients of our study group suggests that there might be a susceptibility of recombination in patients with this kind of hematological malignancies. Cicatricial pemphigoid (CP) and bullous pemphigoid (BP), both associated to HLA DQB1*0301, are characterized by circulating antibodies against the hemidesmosomal protein BP 180. The different clinical features between both diseases correlate with different target epitopes on BP 180. We searched for a correlation between the HLA susceptibility of the diseases and the target epitopes.
Therefore we developed an ELISA based on fusion proteins to investigate epitopes and subclass specifi cities of auto reactivity against NH2 regions and COOH terminal.
Fourteen patients have been tested: anti BP180 NH2 is detected in 8 patients, of whom 5 are HLA DQB1*0301 positive. HLA DQB1*0301 allele is present in 5/6 patients without anti BP180-NH2. BP-180 COOH epitopes was observed only in 1 case.
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GENETIC SUSCEPTIBILITY TO TUBERCULOSIS: ASSOCIATION WITH HLA CLASS II AND TNF-A ALLELES Cláudia Carvalho1,2, Clara Pereira2, Raquel Duarte3, Sara Casimiro2, Zulmira Quintas1, Paulo P.Costa1, Berta M. Silva1,2 1 INSADr. Ricardo Jorge -Porto. 2Immunogenetics Laboratory -ICBAS/Universidade do Porto. 3CDP and CHVNG. Portugal.
The infl uence of genetic components in the susceptibility to Tuberculosis (TB) has been suggested in numerous studies. Association with HLA (Goldfeld A, 1998 , Ravikumar M,1999 , and Tumour Necrosis Factora (TNF-), (Letizia Scola et al, 2002) has been reported in several populations.
The aim of this study is to analyze the association between HLA class II and TNF-alleles with TB in a Portuguese population.
Sixty-eight patients and 42 individuals with known daily exposition to the M. tuberculosis (healthy exposed -HE; 31 with positive and 11 negative Mantoux test) were studied. As control population (CP), a group of 200 healthy individuals was studied. HLA and TNF typing were performed using sequence specifi c primers (PCR-SSP). A decreased frequency of the DRB1*15 allele in TB and HE was observed (15,2% and 11,9%, respectively), comparatively to CP (20.8%). Taking into account the Mantoux test, the frequency of DRB1*11 was increased in the negative group, compared with TB (36% vs 18,2%, respectively). A signifi cantly decreased frequency of TNF-alleles, -308A and -238A, was observed in the HE when compared with the CP (14,2% vs 32,8%; p=0,029, OR= 0,341 and 2,3% vs 14,1%; p=0,046, OR= 0,149, respectively).
These results suggest that TNF polymorphisms could have a direct functional impact, or may constitute a marker for other genes implicated in TB susceptibility. This observation, as pointed by Letizia Scola et al, is probably conditioned by the specifi c genetic background of the population under study. Chonic lymphocytic leukemia (CLL) is a monoclonal malignancy characterized by a progressive accumulation of functionally incompetent lymphocytes. The etiopathogeny of the disease seems to be infl uenced by genetic factors wich may explain its differential epidemiological distribution.
The aim of this study was to investigate HLA-C genotype frequencies in CLL-B patients. HLA-C genotypes of 98 patients were compared with those of 194 population controls. HLA-C alleles were determined by polymerase chain reaction and hybridisation of the amplifi ed products to specifi c oligonucleotides probes (PCR-SSO). SPSS sofware was used for the statistic analysis.
HLA-Cw*16 was found to be signifi cantly increased in patients compared to controls (allele frequency of 27.6 % vs 12.4 %, p=0.0012, Pc=0.016). The frequency of HLA-Cw*08 was also increased (allele frequency of 13.3 % vs 5.7 %, p=0.011). HLA-Cw*07 one the most frequent allele in the population, is by contrast slightly decreased in the CLL-B patients group (allele frequency of 36.6 % vs 46.9 %, p=0.007). These two last associations were not signifi cant after Bonferroni correction. The dimorphism at position 80 of the )1 helix of HLA-C molecules was also studied, and no signifi cant differences were found.
CONCLUSIONS: These fi ndings suggest that genetic factors from HLA-C may be associated with the susceptibility and pathogenesis of CLL-B.
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MCP-1 CHEMOKINE POLYMORPHISM IN CZECH PATIENTS WITH MYOCARDIAL INFARCTION
Zuzana Cermakova*, Jana Petrkova ¶ , Frantisek Mrazek*, Jiri Drabek*, Jan Lukl*, Martin Petrek* *Tissue Typing Laboratory, Department of Immunology and ¶ Department of Internal Medicine I, Medical Faculty, Palacky University Olomouc, Czech Republic; e-mail: petrekm@fnol.cz
Monocyte chemoattractant protein (MCP)-1 is the most important chemokine in the process of atheroslerotic vascular infl ammation. Examining already reported+ association between coronary artery disease and the SNP A/G in the MCP-1 gene (position -2518),139 Czech patients with myocardial infarction (MI) and 359 unrelated control (C) subjects were genotyped by PCR-SSP. Genotype & gene frequencies were not different in MI and C groups (allele G: MI, 20.5%; C, 23.8%, OR=0.76, p>0.05). No differences were detected when the patients were subdivided based on sex or age of MI fi rst occurrence. The data do not support a role for MCP-1 polymorphism in susceptibility to coronary artery disease. We have been currently replicating this association study in a second set of patients and control subjects. This should enable us to conclude if MCP-1 polymorphism is to be deleted from the list of risk factors of myocardial infarction at least for the Czech population. POPULATION AND METHOD: One hundred and twenty three couples with primary recurrent spontaneous abortions characterized by 2-7 miscarriages were investigated in our Institute. On the basis of a welldesigned diagnostic protocol couples with RSA of alloimmune origin (n=97) can be separated from the ambiguous cases (n=29). As controls fertile couples and individuals with family (n=181) were tested.
HLA-A, -B and -C typing was performed by the standard NIH microlymphocitotoxicity method (NIH). HLA-DRB1 and -DQB1 alleles were determined by low resolution molecular technique. HLA-G alleles were detected by PCR-RFLP and PCR-SSP technique: with the used technique 7 (G*01011, 01012, 01013, 0103, 0104, 0105N and 0106) alleles and the 14 bp deletion polymorphism were detectable. Allele frequencies were compared by Fisher's exact.
RESULTS: The HLA-G*0104, 0105N and 0106 alleles showed higher prevalence in the patient's group than in controls. Distribution of the 14-bp insertion/deletion in exon 8 was different between normal and RSA samples.
DISCUSSION: The contradictory results of different studies could be explained by differences in the selection criteria distinguishing cases with alloimmune background from those with non-immunological causes or with autoimmune symptoms as well. Despite of the huge number of haematopoietic stem cell donors represented in various Registries some patients lack a suitable unrelated HLA matched donor (in HU 12%). Recruitment of certain ethnic minorities has been implemented to increase the diversity of registry. We present result on our comparative analysis of the Hungarian Bone Marrow Donor Registry based on the ethnic distribution of Hungarians, Gypsies and Changos.
POPULATION METHOD HBMDR was expanded recently in the framework of EU MADO consortium project with donors of Gypsy (N=176; 3% of registry) and Chango (N=78; 1.5%, not yet registered) origin. Polymorphism of HLA genes and 16 HLA microsatellites was studied at three levels: phenotype, allele and haplotype frequencies were computed. Haplotype frequencies and genetic distances allow us to analyse differences between the populations. RESULTS: Hungarian donors share the most frequent HLA haplotypes in Europe and some others more frequent in Eastern and Southern Europe. As expected, ethnic minorities shows particular haplotypes: for Gypsies HLA-ABDR 1-61-14, 1-57-17, 32-27-16, for Changos HLA-ABDR 24-7-4, 2-44-17: seem very specifi c from these populations). DISCUSSION: These theoretical fi ndings suggest that donor selection process from minorities increase the registry HLA diversity. More population genetics and statistical analysis would benefi t the Registries management. Ethical issues raised by the use of genetic markers in minorities populations should be taken into account.
Performed within the MADO EU consortium www.euromado. 
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Microsatellite polymorphism of MIC-A gene is known genetic risk factor for type 1 diabetes mellitus (T1DM) development in several populations. To investigate the association of the MIC-A microsatellite polymorphism with the adult-onset T1DM and latent autoimmune diabetes in adults (LADA) in Czech population we analysed this polymorphism in 49 patients with adultonset T1DM, 66 LADA patients and 140 healthy control subjects. We found increased frequency of MIC-A5.1 allele in adult-onset T1DM patients with corrected P < 0.01. Differences in allele distribution found between the LADA group and control subjects did not reach statistical signifi cance. However the genotype distribution in both tested groups of diabetic patients was different when compared to frequencies found in the control group but these differences also did not reach statistical signifi cance. In conclusion, the results in this study suggest that microsatellite polymorphism within the transmembrane region of MIC-A gene is associated with genetic susceptibility to adult-onset T1DM whereas it is not associated with LADA in Czech population. According to our fi ndings we can hypothesize that adult-onset T1DM and LADA may have partly different immunogenetic etiopathogenesis.
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HLA-CLASS II (DRB,DQA1 & DQB1) ALLELES AND HAPLOTYPES FREQUENCY IN IRANIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
Amirzargar Ali-akbar, Noorashrafadin mehdi, Khosravi Farideh, Alimoghdam Kamran, Ghavamzadeh Feridoun, Ansaripour Bita, Moradi Batool, Nikbin Behrooz Dept of Immunology and Dept of hematology oncology and BMT, Medical school, Tehran university of medical sciences.
Chronic myeloid leukemia (CML) is characterized by the presence of Philadelphia chromosome resulting from bcr/abl translocation. The bcr/ abl fusion proteins are immunogenic and the junction sequence are HLA restricted. To clarify the association between HLA -class II alleles and haplotypes frequency in CML , 50 ( 18-69 years old mean 44.6, 24 males and 26 females) patients have been selected from hematology oncology and BMT center shariaty hospital Tehran-Iran and compared with a group 80 healthy blood donor subjects. HLA-DRB1,B3,B4,B5, HLA-DQA1 and DQB1alleles were determined using PCR-SSP technique. The results of our studies showed the frequencies of HLA-DQA1*0505(Pv=0.03) , DQB1*03011( Pv=0.01) , DRB1*11(Pv=0.19) were high and the frequencies of DQA1*0201 , DQB1*03032. DQB1*0604, DRB1*1302 were low in comparison to healthy individuals. The most frequent haplotype in CML patients was HLA-DRB1*11, DQB1*03011, DQA1*0505 (Pv=0.03). In conclusion it is suggested that positive and negative association between certain alleles and haplotype and CML patients have been exist.
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A TYPICAL LINKAGE BETWEEN HLA DRB1 AND DQB1 GENES.
Giuseppina Ozzella, Palmina I. Monaco, Angela Iacona, Claudio Cortini, Antonina Piazza and Domenico Adorno. C.N.R. Institute for Organ Transplantation and Immunocytology-S. Eugenio Hospital, P.le Dell'Umanesimo 10-00144 Rome, Italy An unusual HLA-DR15, -DQ4 association was detected in siblings of Caucasian race. Searching for a related bone marrow donor, the patient suffering from multiple myeloma and his relatives were HLA typed. PCR-SSP low resolution typing of patient and his matched siblings were DRB1*07, 15 and DQB1*03, 04. DQB1*03 reaction patterns were specifi c for 0303 or 0306 alleles. These results suggested the presence of the classical DR7-DQ9 phenotype and of an unusual DR15-DQ4 phenotype. The mismatched brother showed the other two classical parents' haplotypes. All individuals were then studied by PCR-SSP high resolution typing. Results showed the classical association DRB1*0701, DRB4*01030102N, DQA1*0201, DQB1*0303 (DR7-DQ9 phenotype) and the atypical association DRB1*1501, DRB5*010101, DQA1*0401, DQB1*0402 (DR15-DQ4 phenotype). This last phenotype was in contrast to already known linkages. Our results supported the hypothesis that the recombinant haplotype might result from a crossing over between DRB1 and DQA1 genes already occurred in the past. Recombination between these genes are rarely observed. Studies of unusual HLA DR-DQ associations may be interesting mainly when the patient has no HLA-identical sibling donor, because potential unrelated donors are probably DQB1 mismatched. Moreover, it was highlighted, in renal transplantation, that the development of DQ donor-specifi c antibodies resulted in a negative prognostic factor for graft outcome. Our data underlines the importance to include DQ matching in selection criteria also for solid organ allocation. AA is an autoimmune and polygenic disorder affecting the hair follicle. An association with HLA-DR11 antigen has been previously shown. In autoimmune diseases such as psoriasis or diabetes mellitus type I, existence of an HLA association indicates a clinical course different to the forms not associated with HLA. We investigated age of onset and gravity of the disease in 88 severe AA patients in relationship with presence or absence of HLA-DR11. Among them, a signifi cant DR11 association (36.3 vs 21.2% in controls; p = 0.004; RR = 2.1) was confi rmed. No predominance of any DR11 subtype was observed. The DR11+ AA subset was characterized by an earlier onset of the fi rst patch = mean age in DR11+ = 16.4 ± 2.6 vs 27.3 ± 2.3 ys in DR11-; p = 0.03) and a signifi cant excess of patients with fi rst patch appearing prior 20 years ( 72 vs 40%; p = 0.0065). Concerning gravity of the disease, no signifi cant difference in terms of AT/AU vs non AT/AU forms appeared. Our fi ndings suggest that the DR11 mediated form of AA is related to an earlier age of onset but not to a more serious form of the disease. Although less spectacular, this proportion is reminiscent of what is observed in type I psoriasis in which HLA-Cw*0602 is present in 75% of the patients.
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ASSOCIATION OF HLA-DRB1 ALLELES WITH SEVERITY OF SARCOIDOSIS
Zorana Grubic, Renata Zunec, Tatjana Peros-Golubicic, Vesna Kerhin-Brkljacic Tissue Typing Centre, University Hospital Zagreb, Zagreb, Croatia
In the present study we investigated distribution of HLA-DRB1 alleles among 90 patients with sarcoidosis and 141 controls. All individuals were typed by PCR-SSP method.
Analysis of DRB1 alleles showed signifi cant differences for DRB1*11 and DRB1*0301 allele. DRB1*11 was signifi cantly more frequent (p=0.0051) in patients with chronic onset of disease in comparison with controls, while higher frequency of DRB1*14 (7.0% vs. 4.3%) and lower frequency of DRB1*07 (3.5% vs. 9.6%) were marginally signifi cant. In patients with acute onset of disease DRB1*0301 allele was signifi cantly more frequent (p=0.0021). Among 36 patients with acute (erythema nodosum-EN) or chronic skin sarcoidosis DRB1*0301 allele was also present with statistically signifi cant higher frequency (p=0.00004) compared with controls. However, patients with no-skin sarcoidosis (N=54) demonstrated higher frequency of DRB1*11 allele (p=0.026). Patients with chest Xray stage I showed signifi cantlly higher presence of DRB1*0301 allele (p=0.00064), while patients with chest X-ray stage II and III showed lower presence of DRB1*11 allele (p=0.0155) in comparison to control group.
This study demonstrates that DRB1 Hereditary hemochromatosis (HH) is one of the most common metabolic abnormalities, inherited as an autosomal recessive trait, and the disease gene (HFE) has been identifi ed. There are three main mutations associated with HH: C282Y, H63D and S65C. Other mutations have been reported although most of them have been found in only one HH patient. One of them, ISV2+4T>C, has been described as a likely splicing mutation. On the other hand, the proximity of the HFE gene to the MHC has allowed different linkage disequilibria between HLA-alleles and HFE mutations to be identifi ed: C282Y and HLA-A3/B7, H63D and HLA-A29/B44, and S65C and HLA-A26.
The aims of this work are: i) to study whether IVS2+4T>C may have a HH phenotypic effect, and ii) to study whether this variant is in linkage disequilibrium with HLA. We studied 65 Spanish probands with a presumptive diagnosis of HH that were heterozygous for C282Y and negative for H63D and S65C. In 23 individuals homozygous for C282Y, none of them carried the intronic variant; indicating that the presence of the C282Y mutation excludes the presence of IVS2+4T>C in the same chromosome. The allele frequency of IVS2+4T>C in C282Y-heterozygous individuals (32%) was not statistically different from the control group (34,8%). In addition, in the control group, 11.4% individuals were homozygous for IVS2+4T>C, leading us to think that this intronic variant is not a mutation that produces HH.
Finally, we have found that IVS2+4T>C is in linkage disequilibrium with the HLA-A29/B44 haplotype and is older than the H63D mutation.
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ASSOCIATION OF HLA-DQB1*0301 ALLELE AND MUCOUS MEMBRANE PEMPHIGOID IN ITALIAN PATIENTS Maria E. Fasano1, Ennia Dametto1, Marco Carrozzo2, Sergio Gandolfo2, Roberto Broccoletti2, Giorgio Bertolusso2, Emanuele Cozzani4, Sabina Rendine3, Stefano Roggero1, Aurora Parodi4, Antonio Amoroso1,3 1Transplantation Immunology Service, S. Giovanni Battista Hospital, 2Oral Medicine Section, School of Medicine and Dentistry and 3Department of Genetics, Biology and Biochemistry, University of Turin, Italy; 4 Dermatology Section, University of Genova, Italy.
Mucous membrane pemphigoid (MMP) is a group heterogeneous of rare immune-mediated sub epithelial blistering diseases. Previous studies have shown the increased occurrence of the HLA-DQB*0301 allele, mainly in patients with ocular cicatricial pemphigoid (OCP), whereas in patients with pure oral pemphigoid (OP) the data are almost questionable. In this study we compared DQB1 alleles typing in 41 MMP patients, 29 of them with exclusive oral involvement, with 97 healthy controls; all individuals were Italian Caucasians. HLA-DQB1 high resolution typing was performed with a PCR-SSP method (Dynal). HLA-DQB1*0301 frequency was signifi cantly increased in patients compared with controls (93 % vs 48%, pc = 0.001, RR= 28.73), as well as homozygous genotypes for this allele (49% vs 8%, pc<0.001, RR= 8.34). A strong association with this allele was also evident in patients with OP only (90% vs 48% in healthy subjects, pc= 0.01, RR= 20.21). Our data suggest that also patients with MMP predominantly affecting the oral cavity present the same genetic predisposition associated to HLA-DQB1*0301, which was previously reported mainly in patients with ocular pemphigoid. Material and Methods : 40 pts had DR; 46 were used as a control group. AR2 fragment, containing C(-106)T, was amplifi ed by PCR and digested with BfaI.
Results The frequency of C(-106)T is signifi cantly higher in patients with DR than those without DR (P<0.0001).
With DR (n=40) No DR (n=46) Genotype CC 9 32 CT 29 7
TT 2 7
Conclusion: 1) This study confi rms the previously identifi ed association of C(-106)T polymorphism with the development of DR; 2) The size of our study population should be increased in order to investigate the development of DR in patients with DM Type I and Type II, separately. The individual differences among the polymorphic regions of the cytokine genes involved in the pathogenesis of myeloma have been investigated by various groups. With an aim to analyze the association between the frequencies of the cytokines known to be important in the pathogenesis of Myeloma, TNFalpha, IL-6, IL-10 and response to Thalidomide, we have isolated DNA from peripheral blood of 29 patients. Patients with a median age of 59(42-83)M/F:19 /11 diagnosed and treated in our center between 2002-2004 were analyzed. All patients received Thalidomide 200-400 mg/day for a minimum duration of two months. Response was determined according to EBMT criteria. Evaluation of results was done based on interpretation and defi nition of phenotypes(low and high secretory patterns) according to the previously published reports. TNF-A homozygous allele could not be observed among all patients. The frequencies of both TNF-alfa 238A TNF-alfa 308A alleles was:21% but not on the same patients. IL-10 1082 GCC/ACC/ATA 16%(high), 58%(intermediate), 25%(low) respectively. IL-6 GG/GC alleles which have been linked with high secretory pattern constituted the majority of the patients(29/29). TNF-238A genotype patients gave a better response to Thalidomide (83% vs 39%) compared to the TNF-238G genotype(p=0.054).This fi nding was not valid for the 308 bp location. Khi square analysis revealed a signifi cant association between younger age, TNF-238A allele and better response(p=0.014). IL-10 phenotypes were more complicated with an accumulation in the intermediate level of secretion. The analysis of TNF-alpha genotype within this group did not show any impact of A allele. When we analyzed patients who did not receive Thalidomid among a total of 59 patients there was a trend to TNF-alpha A(high) and IL-10 A(low) allele among patients younger than 55 (ASH2004). Conclusion: Cytokine gene SNP's such as TNF-alpha 238 is associated with response and earlier age of onset in myeloma. However all our patients carried the IL-6 genotype reported to be associated with high secretory pattern. Investigation of other genes in linkeage with TNF on the neighboring MHC region may be necessary for understanding the molecular pathogenesis of this association. The individual differences among the polymorphic regions of the cytokine genes involved in the pathogenesis of myeloma have been investigated by various groups but none of these groups have analyzed the impact of these genotypes on age of onset. With an aim to analyze the association between the frequencies of the cytokines known to be important in the pathogenesis of Myeloma, TNF-alpha, IL-6, IL-10 and the age of diagnosis, we have isolated DNA from peripheral blood of 59 patients. Patients with a median age of 56(28-83)M/F:35/24 diagnosed and treated in our center between 2002-2004 were analyzed. Interpretation and defi nition of phenotypes(low and high secretory patterns) were based on the previously published reports. 30 patients(50,8%) were younger than 56 (median=the cutoff:56). TNF-A homozygous alelle couldnot be observed among all patients. The frequencies of all alleles were: TNF-alfa308A, TNF-alfa238A, IL-10 1082 G 20%, 20%, 12% respectively. IL-6 -GG/GC alleles which have been linked with high secretory pattern constituted the majority of the patients(58/59). When TNFalfa-A were detected based on the 238 bp reactivity the association of low phenotype with elder age was remarkable(p=0.019). This fi nding was not valid for the 308 bp location. IL-10 phenotypes were more complicated with an accumulation in the intermediate level of secretion. The impact of TNF was varifi ed with the separate evaluation of this group, based on their TNF-238/308 genotype, p=0.031). Conclusion: There is a trend towards younger age of onset in Myeloma. Genetic factors for susceptibility have not been defi ned yet. In our prospective study we have found a predominance of low IL-10 secretory A genotype and the high secretory TNF-A genotype among patients younger than 56. To our knowledge this is the fi rst report on such an association. Investigation of other genes in linkeage with TNF on the neighboring MHC region may be necessary for understanding myeloma pathogenesis. The well recognized predisposition of HLA-DRB1*04 allele carriage, to RA is present in Portuguese population (p<0.0001). HLA-DRB1*10 is also associated to RA susceptibility in the probed population (AR-6,1%vs.C-2.3% p=0.035), as reported elsewhere for Mediterranean populations. It is also noted a correlation of HLA-DRB1*04/10 positive patients to disease activity according to Disease Activity Score 28 (DAS) from EULAR (DAS£3.2-40.9%vs. DAS>3.2-68.3% p=0.003).
Cytokine gene polymorphisms show a weaker association to RA susceptibility. IL-1 cluster genotypes IL-1R 970TT (p<0.05), IL-1Ra 2017TT (p=0.027) and IFN-g 874 TT (p<0.05) frequencies overcome in RA patients compared to control population. Remission to moderate disease activity scores (DAS£3.2) are associated to the IL-1b -511TT genotype (p<0.05), while at higher disease activity score patients (DAS>3.2) it was found a higher frequency of the TNF-a 488G/-238G/-308A haplotype (p=0.035).
High titers anti-CCP antibodies a highly correlated risk factor development of RA are signifi cantly to HLA-DRB1*04/10 presence (anti-CCP<50-27,8% vs anti-CCP³50 60% p<0.05).Reumatoid factor IgA low titers (<50U/L) were correlated to IL-1RA 2017 TT (p<0.05) while IFN-g 874 AA genotype frequency were signifi cantly higher in RF IgM high titers (>50 U/L) (p=0.001). In conclusion in a Portuguese population of RA affected patients HLA DRB1 remains the highest genetic factor of the disease susceptibility, associated also to disease activity and anti-CCP antibodies titer previously shown as highly predictive of RA development. Genetic polymorphism of other immunoregulatory molecules shown weaker association, but IL-1gene cluster polymorphisms is identifi ed as a potential genetic region that further investigation could reveal as a risk factor for RA development. Rheumatoid arthritis (RA) is an autoimmune disorder that manifests as a chronic destructive joint disease. The susceptibility to RA is mainly modifi ed by HLA-DRB1 loci, however, cells outside the HLA class II region are also part of the genetic background for disease susceptibility. By secreting various lymphokines natural killer (NK) cells provide a milieu that favours the activity of regulatory and effector T lymphocytes. Functionally NK cells are regulated by the balance of inhibitory and activating signals derived via cell surface molecules. Those receptors include the killer cell immunoglobulin like receptors (KIRs) that are encoded in a gene cluster at chromosome 12. We addressed whether the polymorphism of that gene cluster would help identifying genes associated with RA. We analysed the presence of KIR genes in the genotypes of twenty patients and healthy controls by typing genomic DNA by PCR with a set of sequence specifi c primers. In addition HLA-C molecules the ligands of the KIR2D subfamily have been typed. The distribution of KIR genes and the KIR2D ligands between healthy controls and patients did not show any signifi cant differences, indicating that the haplotypic polymorphism of KIR genes is not involved in disease susceptibility.
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NO OBVIOUS ASSOCIATION BETWEEN KIR GENE
70
POSITIVE ASSOCIATION OF TNF-857 AND IFN γ 874 GENE POLYMORPHISMS WITH CHRONIC FATIGUE SYNDROME
Nicoletta Carlo-Stella, Carla Badulli, Annalisa DeSilvestri, Laura Salvaneschi, Miryam Martinetti, Mariaclara Cuccia. Dept. of Genetics and Microbiology, University of Pavia, v. Ferrata 1, 27100 Pavia, Italy Chronic fatigue syndrome (CFS) is characterized by debilitating fatigue that lasts for more than six months and reduces the patient's daily activities by at least 50%. It includes neurological symptoms, swollen lymph nodes and immunological abnormalities such as a reduced NK cell activity. Its etiology remains unknown. No treatment exists and there are no predictive markers. A new entity, "sickness behavior", in which symptoms are similar to CFS and has a homeostatic function in infectious diseases, has been defi ned as a cytokine imbalance with a marked increase in pro-infl ammatory cytokines. Literature data on serum cytokine concentration in CFS have been inconclusive. In order to understand whether this is an epiphenomenon or a genetic susceptibility to CFS, we enrolled 54 patients with certifi ed CFS and investigated the following cytokine gene polymorphisms by PCR-RFLP and by PCR-SSP: TNF-307, TNF-857, IL-10-1082, IL-10-819, IL-10 -592, IL-6 -174 and IFN-874. The following were statistically signifi cant (*p=0.005 and **p=0.04): These preliminary results show a signifi cant increase in TNF high producers and a signifi cant decrease in IFN g low producers. This could imply a Th1 phenotype and an evolutionary adaptive mechanism for non cytolytic viral elimination. In the Rheumatoid Arthritis (RA) project, 13 submitter provide access to data of 1761 individuals (918 cases, 843 controls) of 14 populations, typed for DRB, DQB and to a smaller extend for HLA-A, B, and C. 12 microsatellites within the extended HLA region have been typed. A variety of RA specifi c clinical parameters have been recorded.
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STUDY OF HLA GENES IN CUBANS AND THEIR RELATIONSHIPS WITH AMERINDIANS, EUROPEANS AND AFRICANS
In the Type 1 Diabetes project (T1D), 29 submitters provide access to data of 7146 individuals, half family data, half unrelated case control studies of 21 populations, typed for DRB, DQB and DQA. DR/DQ haplotypes have been generated and can be downloaded or used to generate data subsets. 8 micro-satellites within the extended HLA region have been typed. A subset of data contains additional T1D specifi c parameters.
Users can download either the entire dataset or submit queries in order to retrieve specifi c subsets. Downloads can either be received in form of aggregate functions or as the complete listing of all or a limited selection of data available.
Both resources will be publicly accessible by end of HLA Class I typing was performed using the ARMS-PCR approach. Primers were carefully selected from a modifi ed 12WS primer set to represent the broad specifi cities with as few primer pairs as possible. PCR products were detected by AMDI, and two healthy cohorts of 80 British and 70 Orcadians were used. This low resolution typing gave us information about 55 HLA-A, B and C alleles. The use of prior knowledge of linkage disequilibrium (LD) in this region of HLA allowed us to convert 55 HLA alleles into 80 SNPs and vice versa. Converting alleles to SNP haplotypes extends the use of the data for both classical HLA studies and SNP based projects. The mutation responsible for most cases of genetic haemochromatosis in Europe (HFE C282Y) appears to have been originated as a unique event on a chromosome carrying HLA-A3 and -B7. It is often described as a "Celtic mutation"-originating in a Celtic population in central Europe and spreading west and north by population movement. It has also been suggested that Viking migrations were largely responsible for the distribution of this mutation. Two, initial estimates of the age of the mutation are compatible with either of these suggestions. Here we examine the evidence about HFE C282Y frequencies, extended haplotypes involving HLA-A and -B alleles, the validity of calculations of mutation age, selective advantage and current views on the relative importance of "demic-diffusion" (population migration) and "adoption-diffusion" (cultural change) in the neolithic transition in Europe and since then. We conclude that the HFE C282Y mutation occurred in mainland Europe before 4,000 BC.
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THE EUROPEAN CELTIC/VIKING ORIGIN OF THE C282Y (AND OTHER) HEMOCHROMATOSIS MUTATIONS
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THE ORIGIN OF TARAHUMARA MEXICAN AMERINDIANS ACCORDING TO HLA GENES. Tarahumaras are unexpectedly genetically close to geographically and linguistically distant South American Aymara and Terena Amerindians (from Bolivia highlands and Brazil-Paraguay lowlands, respectively) than to other Amerindian neighbouring populations.
It is also observed that all Amerindians represent a separated group from other world populations (including Na-Dene, Eskimos and Siberians). This confi rms an unanticipated complexity in the Amerindian migration patterns and also that languages and genes do not correlate.
REFERENCES: High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian Population. Garcia-Ortiz JE, Sandoval-Ramirez L, Rangel-Villalobos H, Maldonado-Torres H, Cox S, Garcia-Sepulveda CA, Figuera LE, Marsh SGE, Little AM, Madrigal JA, Arnaiz-Villena A, Moscoso J, Arguello JR. In press (2005).
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ASSOCIATION OF A FUNCTIONAL SINGLE NUCLEOTIDE POLYMORPHISM OF PTPN22 WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS.
Gisela Orozco, Elena Sánchez, Belén Torres, Antonio Nuñez-Roldan, Mª Francisca González-Escribano, Javier Martín. I. P. B. López Neyra, CSIC. P. T. de Ciencias de la Salud. Avenida del Conocimiento s/n 18100-Armilla (Granada), Spain. Tel.: +34-958-181669. Fax: +34-958-181632 The aim of this study was to assess the possible association between the PTPN22 gene 1858C→T polymorphism and two systemic autoimmune diseases, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Our study population consisted in 826 RA patients, 338 SLE patients and 1036 healthy subjects of Spanish Caucasian origin. Genotyping of the PTPN22 gene 1858C→T polymorphism was performed by real time PCR technology, using TaqMan 5' allelic discrimination assay. The overall distribution of genotypes in the RA patients was signifi cantly different from that in the controls (P = 0.005, by chi-square test from 2 x 3 contingency table). We observed a statistically signifi cant difference in the distribution of the PTPN22 1858 T allele between healthy subjects (7.4%), and RA patients (10.4%) (P = 0.001; OR=1.45, 95% CI 1.15-1.83). In addition, PTPN22 1858 C/T and T/T genotypes were present at signifi cantly higher frequency in SLE patients than in controls (P = 0.02; OR= 1.55, 95% CI 1.05-2.29). Differences were also observed when allelic frequencies were compared, the PTPN22 1858 T allele was present at a higher frequency among SLE patients (P = 0.03; OR=1.45, 95% CI 1.01-2.09). These results indicate that the PTPN22 1858 T allele confers differential susceptibility to RA and SLE in our population.
77
DIFFERENCES IN ALLELE FREQUENCIES IN CYTOKINE GENES BY POPULATIONS: IMPLICATIONS FOR MOLECULAR EVOLUTION AND SELECTION OF CANDIDATE GENES FOR ASSOCIATION STUDIES
Meredith Yeager, Min Shen, Guilan Li, Xingzhou He, Robert Welch, Tongzhang Zheng, Stephen Chanock, and Qing Lan, CGF, DCEG, NCI, HHS 8717 Grovemont Circle, Gaithersburg, MD 20877 A major contributing factor to inter-individual variation in circulating levels of cytokines is germ-line genetic variation. Common genetic variants in cytokine genes have been associated with susceptibility or progression of a spectrum of diseases, such as autoimmune disorders, cancer, cardiovascular disease and infection. Many studies have investigated the most common type of variation in cytokine genes, single nucleotide polymorphisms (SNPs). While SNPs have been associated with the risk or outcome of common and rare diseases, striking disparities in allele frequencies among human ethnic groups have been observed. These observations suggest that select genes have evolved separately in different geographic regions due to differential selective pressures. Consequently, genes in which the genetic diversity measure is substantially different could represent suitable candidate genes to investigate specifi c diseases or outcomes that have been observed to differ by ethnic or geographic population.
To address this question, we examined 55 common SNPs drawn from 34 cytokine genes analyzed in separate population-based studies. Control samples were analyzed (N=253 individuals from China and N=547 individuals of European ancestry) and we observed statistically signifi cant differences in allele frequencies for a subset of cytokine SNPs, the most striking difference between the two populations was observed in analysis of 4 SNPs spanning approximately 9kb of the interleukin 4 (IL4) gene (mean FST = 0.791). Preliminary analysis suggests limited haplotype diversity within the 2 populations, and the existence of highly divergent, or yin-yang, haplotypes between them.
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HLA CLASS I AND CLASS II ALLELES DISTRIBUTION OF A GUANGDONG CHINESE HAN POPULATION DEFINED BY SEQUENCE-BASED TYING
Li Yan, Tang Xue-wei, WU Jie-ying, Yuan Si-min, Yang Xin, Huang Yining, Liao Can. Guangzhou Cord Blood Bank, Guangzhou Maternal and Neonatal Hospital, Guangzhou 510180, China
We investigated the genetic polymorphism of HLA class I/II alleles in Guangdong Chinese Han population (n= 437) and compared with different populations. The sequences encompassed exon 2/3/4 for HLA-A/B were analyzed by direct sequencing of PCR products. For HLA-DRB1, the exon 2 was analyzed with three sequencing reactions -one forward, one reverse and one specifi c for Condon 86. A total of 28 HLA-A, 55 HLA-B and 36 HLA-DRB1 alleles were found. Three HLA-A alleles (A*110101, A*24020101/02L and A*0207), three HLA-B alleles (B*400101/02, B*4601 and B*1502) and three HLA-DRB1 alleles (DRB1*090102, DRB1*120201, and DRB1*150101) were present at a frequency greater than 10%. Four HLA-A and HLA-B haplotypes (A*0207-B*4601, A*110101-B*1502, A*110101-B*400101/02, A*3303-B*5801) were present at frequencies greater than 5%. Comparison of the HLA-A and HLA-B frequencies with different population showed a close relationship with Chinese populations from Hong Kong and Singapore, respectively. But there were some differences at HLA-A and HLA-B haplotypes. These data will infl uence the donor search strategy and the stem cell registry's fi nal capability.
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CARD15 POLYMORPHISM IN ABDOMINAL AORTIC ANEURYSM (AAA).
Esther Ocaña, Juan C. Bohórquez, José A. Brieva, Antonio Nieto. Serv. Inmunología. Hospital Puerta del Mar. Cádiz, Spain.
Chronic transmural infl ammation is one of the principal histologic features of established AAAs and accumulating evidence suggests that infectious agents, particularly CMV and C. Pneumoniae, may play a role in its pathogenesis. On the other hand, genetic factors are likely to be involved in susceptibility to the common forms of aneurysm, as suggested by the familial aggregation of AAA, and evidenced by association and genome scan studies. CARD15 codes for an intracellular sensor of pathogenassociated molecular patterns (NOD2) and plays a role in Crohn's disease and probably in other infl ammatory conditions.
In this work CARD15 polymorphisms were analyzed by PCR-RFLP (P268S, G908R, L1007fs) and PCR-SSP (R702W) in 74 AAA patients and 145 healthy controls from the same referral area. The allele and genotype frequencies in controls were similar to those previously reported in Spanish population. No signifi cant differences were observed between patients and controls for P268S, G908R and L1007fs allele and genotype distributions. However, the 702W allele was signifi cantly increased in AAA patients (11.4% vs 5.8%; P=0.03) corresponding with an increased prevalence of the heterozygote R/W genotype in this group (23% vs 12%; P=0.03; OR=2.25, 1.01-5.02 95% CI). No correlation was found with any of the clinical characteristics analyzed (age, smoking, symptomatology, aortic diameter, occlusive arterial disease, and degree of infl ammation, calcifi cation and neovascularization).
These results suggest that CARD15 polymorphism is involved in genetic predisposition to AAA. Turkish HLA profi les are compared for the fi rst time with European and Asian HLA populations profi le. HLA-A, -B and -DRB1 allele frequencies are obtained from a large Turkish population (n=700); genetic distances (DA), NJ and correspondence analysis include Turks within Middle East / Mediterranean ethnic groups, while Asians are more distant. Turks may be classifi ed within the older Mediterranean substratum (Iranians, Cretans, Macedonians, Armenians, Algerians, etc.). It may be concluded that the Turkish migration into Anatolia was more a cultural (linguistic) than a genetic one and did not imply a relatively big entrance of eastern Asian people.
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HLA-PHENOTYPE FREQUENCIES IN PATIENTS WITH INTRACRANIAL ANEURYSMS.
Stanislav Ferencik1 , Vera Rebmann1, Jens Regel2, Njawe Siewe1, Beate Schoch2, Dietmar Stolke2 , and Hans Grosse-Wilde1 Institute of Immunology1, Department of Neurosurgery2, University Hospital of Essen, Germany Aneurysms are dilatations affecting a part of any vessel wall. Ruptures of intracranial aneurysms (IAs) can lead to subarachnoid haemorrhage (SAH). Results of former studies analysing HLA phenotypes in IA patients were controversial. Thus, our aim was to verify the role of HLA in a larger cohort of unselected IA patients. A total of 194 IA patients were studied, of which 143 (74%) had ruptured (=SAH) and 51 (26%) unruptured (=nonSAH) IAs. For the purpose of this study, the PCR-SSP method was used to type for HLA-class I + class II corresponding to the serologically defi ned specifi cities. As controls 174 random blood and organ donors from the Essen area were used. Comparisons of HLA antigen frequencies between patients and controls were carried out and the strength of the association between IA patients and HLA antigens was given as relative risk (RR). P-values were calculated using the Bonferroni correction (Pc). A signifi cantly increased frequency of HLA-C*06 was found in IA patients group (RR=1.3, Pc<0.08 / SAH: RR=1.9, Pc<0.05 / nonSAH: n.s.) and of HLA-C*16 (RR=11.4, Pc<0.03 / SAH: n.s. / nonSAH: RR=15.4, p<0.0001) respectively. An increased frequency of HLA-DRB1*07 in IA patients confi rmed previously reported data (RR=1.6, Pc<0.03 / SAH: n.s. / nonSAH: RR=1.8 / Pc<0.005). Thus our study, the largest by this disease suggests a new association of HLA-C*06 and HLA-C*16 in patients with IA. The biological relevance of this observations is currently under investigation. The type 1 autoimmune diabetes is positively associated with the HLA-DR3/DQ2 and the DR4/DQ8 haplotypes. The tumour necrosis factor (TNF) alpha promoter polymorphism could modify the disease behavior: the G→A substitution at position -308 (TNF2 allele) is associated with high amount of TNFa production, this could be one of the factors responsible for the rapid b-cell destruction. Our aim was to determine the prevalence of HLA-DR and DQ genotypes and the TNFa polymorphism in type 1 diabetic children and in their healthy relatives. Methods: 37 families (38 type 1 diabetic children, 74 fi rst degree relatives). HLA genotypes and TNFa -238 and -308 polymorphism were determined by PCR. Results: In the examined population 32 persons were TNF2 carriers (41,5%): 25 persons carried the HLA-DR3/DQ2-TNF2 (8.1 ancestral) haplotype, and 7 carried the HLA-DQ8/DR4-TNF2 haplotype. Among the 25 person carrying the 8.1 ancestral haplotype 6 were DR3/4-DQ2/8 heterozygous: all of them had diabetes (100%); 6 persons were DR3/DQ2 homozygous: 3 had diabetes (50%), and 1 person had autoantibody positivity. The other 13 persons carrying the 8.1 ancestral haplotype had a protective haplotype as well against type 1 diabetes (DR13/DQ6, DR11/DQ7, DR16/DQ5): 3 had diabetes (23%). Conclusions: As the person carried the HLA-DR3/ DQ2-TNF2 (8.1 ancestral) haplotype together with another high risk haplotype (DR4/DQ8 or DR3/DQ2), the risk of developing type 1 diabetes (75%; 9/12) was signifi cantly higher, than if the other carried haplotype was protective (23%; 3/13, p=0,01). Sarcoidosis is a multiorgan granulomatous disease of unknown ethiology. Several lines of evidence suggest a genetic predisposition and associations have been shown with human leucocyte antigens. HLA-DQB1 has been proposed as one of the candidate genes. In berylliosis, a granulomatous disease similar to sarcoidosis, a strong association was found between beryllium hypersensitivity and HLA-DPB1-E69.
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The role of each single amino acid polymorphism in sarcoidosis was analysed by performing sequence-based high resolution typing for HLA-DQB1 and -DPB1 followed by univariate analysis for all the amino acid polymorphisms present in HLA-DQ and -DP b-chain in 149 Dutch Caucasian sarcoidosis patients compared to healthy Caucasian controls (n=306 for DPB1 and n=418 for DQB1). Specifi cally, 17 HLA-DPB1 polymorphic amino acid positions including 40 different amino acids and 32 HLA-DQB1 positions with 77 different amino acids were investigated. Signifi cance was determined as p<0,05, calculated by c2 testing with Bonferroni correction.
For DPB1 three amino acids were signifi cantly decreased in the patient group compared to controls, namely L8, F9 (both 86.6% vs 96.1% in controls; pc=0.009, RR=0.49) and M76 (89, 3% vs 97.4%; pc=0.018, RR=0.46) . Four HLA-DQB1 amino acid variants were signifi cantly different between patients and controls. A signifi cant increase was observed for D57 (81.2% vs 51.4% in controls; pc=0.0012, RR=2.97), F9 (38.9 vs 20.8%; pc=0.0024, RR=1.86) and Y30 (85.2 vs 69.6%; pc=0.014, RR=2.06) . A decrease was observed for V38 (52.4 vs 66.8%; pc=0.047, RR=0.65) . These residues are all present in pocket 4, 6 or 9 of the peptide binding groove and have been reported to play a crucial role in peptide binding capability. Possibly they play a role in the presentation of the antigen(s) driving the immune respons involved in the pathogenesis of sarcoidosis.
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CAD (CORONARY ARTERY DISEASE), DIABETES AND HLA CLASS III RAGE (RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS) GENE POLYMORPHISMS.
Ilaria Sbarsi, Chiara Boiocchi, Colomba Falcone, Ilaria Campo, Michele Zorzetto, Maria Paola Buzzi, Miryam Martinetti, Mariaclara Cuccia Department of Genetics and Microbiology, University of Pavia-Italy RAGE is a member of the Ig superfamily coded by a gene located in the HLA class III region. RAGE is a cell surface receptor that plays a key role in infl ammatory processes, in particular RAGE-ligand interaction is a propagation factor in chronic disorders, based on the enhanced accumulation of the ligands in diseased tissues. RAGE interacts with different ligands, including AGEs, S100/calgranulins, amphoterin, and amyloid-peptide. In cardiovascular diseases and atherosclerosis, data suggest roles for AGEs and proinfl ammatory ligands of RAGE in lesion initiation and progression. Furthermore in diabetes, when fueled by oxidant stress, hyperglycemia and superimposed stresses, such as hyperlipidemia, the ligand-RAGE axis amplifi es vascular stress and this leads to an accelerated atherosclerotic process.
In our study we genotyped, for RAGE -374 T/A polymorphism, 279 patients with angiographically documented CAD, 45 of whom have type II diabetes, and 213 healthy, ethnically matched donors (Northern Italy). Our data show a signifi cant decrease of the frequency of the AA genotype in CAD subjects compared with controls (14% vs 23%, p=0.013); moreover in diabetic CAD patients the frequency is more signifi cantly reduced (7% vs 23%, p=0.013), indicating a protective role of the A allele on coronary risk, especially in the more serious pathological condition represented by the diabetic setting. Chromosome region 2q33 encodes several key regulators of the immune system, among these the cytotoxic T lymphocyte antigen 4 (CTLA4), the cluster of differentiation molecule 28 (CD28) and the inducible costimulatory molecule (ICOS). Polymorphisms in this region have been suggested to be associated with development of several autoimmune diseases.
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Involvement of these genes in multiple sclerosis (MS) is not yet clear in spite of a series of studies. Therefore, we investigated a 262 kb region of chromosome 2q33, covering the CD28, ICOS and CTLA4 genes, in a Norwegian MS cohort. Six microsatellites (CD28-A, CD28-B, SARA-43, SARA-1, SARA-31 and SARA-47) and three single nucleotide polymorphisms (SNPs; CTLA4+49, CT60 and CT61) were genotyped.
No associations was observed for any of the markers analysed in the fi rst set up to 302 Norwegian MS patients and 282 controls, nor after including a second set up to 278 Norwegian MS cases and 269 controls in the analysis of the CTLA4 +49, CT60 and CT61 SNPs. Associations were neither found for the SNP markers when stratifying the total MS material for HLA, sex, age at onset, disease course and familial cases of MS.
In conclusion, this study could not confi rm association to the CTLA4 gene region or markers in gene regions nearby in a relatively large Norwegian MS cohort. These results underline the importance of genotyping large materials in genetic studies of complex disorders. Although numerous software packages have been developed to support HLA analyses, these are usually not user-friendly and have not incorporated the latest advances in genetic analysis. DHLAS (Database HLA Analysis System), is a database system used for the management and analysis of HLA data. It has been developed using JAVA (Sun Microsystems), runs on a Java Virtual Machine and its interface is web-based powered by the servlet engine TOMCAT (Apache Foundation). It utilizes STRUTS, a ModelView-Controller architecture and uses several GNU packages for charting, matrix manipulation and others, to perform several of its tasks. The database engine it relies upon for fast access is MySQL, but others can be used as well. An object-oriented approach has been used for handling the data and HIBERNATE, an object-to-relational framework, has been used to achieve that. The system easily calculates all indices required for HLA population studies, such as: Hardy-Weinberg equilibrium (calculated using both a conditional and an unconditional exact test), genetic distances [estimated using different calculation approaches for distances of vectors (Euclidean, Pearsons correlation, uncentered Pearsons correlation, etc.) -phylogenetic trees are constructed using UPGMA (Unweighted Pair Group Method with Averages) and neighbor-joining method], linkage disequilibrium (pairwise and overall, including variance estimations) and haplotype frequencies [estimated using the expectation and maximization (E-M) algorithm]. Prediction of a Msat tag allele is intrinsically limited to particular HLA alleles. Haplotype based prediction strategy appears more globally correlated in population. But due to the lack of phase information in individual genotypes, improving statistical prediction is required. Interestingly, HLA A B DR frequent haplotypes that are heterogeneous at higher HLA resolution seems to be less correlated with microsatellites. In association studies, these data may help to discuss genetic factors in HLA and provide evidence for using particular combinations of Msat based on the linkage disequilibrium. The phylogenetic relationships among wild canary species (genus Serinus) were studied using the cytochrome b molecule gene. These species thrive in Africa and Eurasia. Histocompatibility genes were also sequenced and studied their mode of evolution in this natural population. It is confi rmed their low variability previously found in South American siskins. However, wild canaries from the Canary Islands show a great divergence and variability from other canary species in the neighbouring African continent with respect to these MHC molecules. The hypothesis that isolation and inbreeding lead to more polymorphic histocompatibility systems is supported by our data, which are discussed in the context of the postulated pathogenesis (high variability) of autoimmune diseases linked to hitocompatibility genes.
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TNF-α AND KIR IN COMBINATION OF TYPE 1 DIABETES AND CELIAC DISEASE
Nina Bratanic, Vesna Galvani*, Ruth Rupreht*, Andrijana Ponjavic*, Mirjam Obreza, Tadej Battelino, Blanka Vidan-Jeras* *Blood Transfusion Center of Slovenia, Slajmerjeva 6, 1000 Ljubljana, Slovenia Celiac disease is more prevalent among patients with T1D. The two diseases share susceptibility haplotypes linked to DQ2 and DQ8, respectively. Gut immune system has been implicated in the pathogenesis of both diseases. The high density of TNF positive cells on the intestine was reported. The -308G (TNFA*1) to -308A (TNFA*2) SNP in the promoter was shown to have effect on transcriptional activation of TNF gene and to infl uence predisposition to and severity of autoimmune diseases. Additionally, genome-wide linkage studies suggested candidate region 19q13.4. Intraepithelial T and NK cells in duodenum express KIR molecules, encoded on that region. In Slovenians DQ8 haplotype represents much higher risk factor (OR=29,8) for developing T1D than DQ2 haplotype (OR=3,4). However, 35 out of 474 Slovenian patients with T1D developed celiac disease, 94% of them possessing DQ2 haplotype. TNF gene typing and family analysis showed that 81% of DQ2 haplotypes extend to TNFA*2 allele. In contrast, most of DQ8 haplotypes were linked to TNFA*1 allele. In all patients DQ2 haplotype included Cw7, C1 group ligand for KIRs. Comparison of C1 or C2 group homozygotes possessing activating 2DS1 and 2DS2 between patients and controls showed signifi cant difference (p=0.0007). Imbalance in the regulatory capacity of KIR molecules may facilitate celiac disease. The results of the study add evidence to the theory that a combination of genes synergistically involved in the pathogenesis are required for outburst and development of the disease. Oral Lichen Planus (OLP) is frequently associated to hepatitis C virus (HCV) infection. In a previous work, we have shown that the IFN-g and TNF-a gene polymorphisms contribute to OLP susceptibility in absence of HCV infection.(OLP-HCV-ve). The aim of this study was to evaluate whether the polymorphisms of several cytokine genes may infl uence the susceptibility to OLP in HCV-infected patients.(OLP-HCV+ve). Analysis of 22 polymorphisms inside 13 cytokine genes was performed with "University of Heidelberg Cytokine Typing Tray" (PCR-SSP method). Were included in the study group: 35 OLP-HCV+ve; 44 OLP-HCV-ve and 140 healthy subjects. All were HLA-DRB1-low resolution molecular typed. No signifi cant difference was evident in OLP-HCV+ve patients and healthy controls, whereas IFN-g UTR 5644 genotype A/T frequency showed a signifi cant increase in OLP-HCV+ve patients in comparison to OLP-HCVve (45,7% vs 18,2%, p=0,003). Contrarily, genotype G/A frequency of the -308 TNF-a gene was lower in OLP-HCV +ve patients than in OLP-HCVve (5,7% vs 43,2, p=0,00006). A linkage disequilibrium between allele A of the -308 TNF-a and HLA-DR3 and -DR6 patients was observed only among OLP-HCV-ve. patients. All those data suggest distinct pathogenetic mechanisms between OLP in patients with and without HCV infection.
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ANALYSIS OF CYTOKINE GENE POLYMORPHISMS IN ORAL LICHEN PLANUS HCV-INFECTED PATIENTS
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HLA MICROSATELLITES POLYMORPHISMS AND SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS Thomas Barnetche1, Pierre-Antoine Gourraud1, Anne CambonThomsen1, Alain Cantagrel2, Arnaud Constantin1,2 1INSERM U558, Toulouse, France 2Rangueil University Hospital, Toulouse, France PURPOSE. Rheumatoid arthritis (RA) is a complex, polygenic disease of unknown aetiology. The only region of the genome which was clearly linked to RA is the HLA region. Among HLA genes, HLA-DRB1 alleles encoding the shared epitope (SE) were associated with RA susceptibility and severity. However, other candidate genes could reside within the HLA complex. In the present study, we used a microsatellite (MSat) typing approach to identify other loci associated with RA susceptibility within the HLA complex.
MATERIALS. 170 RA patients (ACR 1987 criteria) and 282 healthy unrelated individuals were included in the present study. A panel of 9 MSat loci (D6S291, G51152, DQCAR II, D6S273, TNFd, MIB, D6S265, D6S2222, D6S2239), spanning the HLA complex, as well as HLA-A, HLA-B and HLA-DRB1 genes, were typed in cases and controls.
RESULTS. Our results confi rmed the association between HLA-DRB1 and susceptibility to RA. Three polymorphisms were positively associated with RA: allele*136 at D6S265 (OR [CI] =1.55 [1.11-2.17], p=0.007), allele*116 at D6S2239 (OR=1.34 [1-1.79], p=0.03) and HLA-A2 (OR=1.46 [1.08-1.98], p=0.01). The positive association between allele*136 at D6S265 and RA remained unchanged after taking into account potential linkage disequilibrium with HLA-DRB1 gene polymorphism.
CONCLUSION. The results of the present study support the hypothesis of a second predisposing locus located within the HLA complex that may infl uence the susceptibility to RA independently of HLA-DRB1 gene. POPULATION AND METHOD: One hundred and twenty three couples with primary recurrent spontaneous abortions characterized by 2-7 miscarriages were investigated in our Institute. On the basis of a welldesigned diagnostic protocol couples with RSA of alloimmune origin (n=97) can be separated from the ambiguous cases (n=29). As controls fertile couples and individuals with family (n=181) were tested.
DISCUSSION: The contradictory results of different studies could be explained by differences in the selection criteria distinguishing cases with alloimmune background from those with non-immunological causes or with autoimmune symptoms as well.
Sponsored by National Health Research grant ETT 486-09/2003 We have already shown critically ill patients show different correlations of subpopulations of WBCs with clinical and haematological parameters e.g. coagulation factors. Especially Diabetes Mellitus during acute phase predisposed differently to fatal outcomes than cancer did, depending on the eosinophil level of blood, prothrombin time and fi brinogen. Our aim is to show data of a general sample of patients with a variety of clinical situations and outcomes and investigate any existing differentiation of WBCs caused by glycaemic level, although, literally, this connection may not reveal causation.
A sample of 742 patients, hospitalised for a variety of acute conditions, was divided in three groups according to the fasting glycaemic level. Normal, with glucose under 6,1 mmol/l. (N). Hyperglycaemic, 6,1 to 8,2 mmol/l (HG). Diabetic, with glucose over 8,2 mmol/l (DM). WBC subpopulations were estimated by differential counting of WBCs measured by SYSMEX haematology analyser. Nonparametric ANOVA (Kruskall -Wallis) and Mann-Whitney two sample comparison testing were used mainly to investigate differentiation.
Age of patients, urea, ESR, WBCs, neutrophils, stab cells and metamyelocytes escalated positively according to glycaemic level, while lymphocytes, platelets, eosinophils climaxed negatively. Non climaxing differentiation was also shown between glucose levels in lymphocytes (concentration), eosinophils (concentration). The same differentiation was not shown when we discriminated the gender. Although neutrophils, stab cells, metamyelocytes, eosinphils seemed not to be climaxed differently by glycaemic level in the two sexes, we have found a profound and signifi cant difference in lymphocytes in DM level. Albeit there was no age difference, women showed a 35 % lower value of lymphocytes in DM level than men, while no difference was present in N and HG level. Platelets also differed signifi cantly between men and women in HG and DM level. Only in men was shown a negative climaxing effect to platelets by glucose level while in women platelets presented a kind of stability through levels. Finally monocytes were not infl uenced by glycaemia although there was a 20% greater value in men, although this difference was not confi rmed statistically in HG and DM level probably due to smaller sample and vast variation.
Our data reveal a possibility that the immune system reacts differently in acute conditions depending on gender and on basic disease. This kind of differences cannot be traced when we have to deal with small samples. DM might have a negative effect in TH2 response probably, if we could ascribe blood eosinophilia to this kind of response, although our work cannot preclude a differentiated mobilization of WBC in DM. In any case this may be proved fatal occasionally. For this reason more research is needed to investigate immune responses in separate clinical sets. The aim of the study was to investigate the relationship between MHC alleles and DMFT index in 65 teenagers. There have been reports of a relationship between human histocompatibility antigen types and increased incidence of dental caries. The association between specifi c patterns of HLA genetic inheritance is not clear and not well studied. The role of HLA class II in the regulation of immunity is well known. Different class II HLA alleles have different functions, thus immunity is determined by the allele structure in this class. We think that immunologic response to cariogenic bacteria is crucially important. In here, the role of HLA alleles or a given pattern of HLA in caries could be value to be considered. Our results showed that HLA-DRB1*04 and -DRB1*07 frequencies were signifi cantly higher (30.4% and 26.08% respectively) in DMFT.1 group as compared with DMFT:0 group (10.5% and 5.26%), (p:0.168, OR:3.719; p:0.117, OR:6.353) . Although frequencies of HLA-A*2, -B*27 and -B*51 alleles were increased in DMFT.1 group, they were not statically important. HLA-DRB1*11 were found to be more common in DMFT: 0 groups.
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